Form 8-K - Current report:
SEC Accession No. 0001104659-24-085604
Filing Date
2024-08-05
Accepted
2024-08-05 07:23:12
Documents
16
Period of Report
2024-08-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2420838d1_8k.htm   iXBRL 8-K 42240
2 EXHIBIT 2.1 tm2420838d1_ex2-1.htm EX-2.1 1069009
3 EXHIBIT 99.1 tm2420838d1_ex99-1.htm EX-99.1 24423
7 GRAPHIC tm2420838d1_ex99-1img01.jpg GRAPHIC 3753
  Complete submission text file 0001104659-24-085604.txt   1566623

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mnk-20240805.xsd EX-101.SCH 3024
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnk-20240805_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnk-20240805_pre.xml EX-101.PRE 22366
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2420838d1_8k_htm.xml XML 3557
Mailing Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 L2 D15
Business Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 L2 D15 353 1 6960000
Mallinckrodt plc (Filer) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | Fiscal Year End: 1227
Type: 8-K | Act: 34 | File No.: 001-35803 | Film No.: 241173094
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)